Michael C. Jensen - Concepedia

Author

Michael C. Jensen

Also Known As

Ahmed Kishk, Ann E. Terry, Jensen, Michael, M C Jensen, M C V Jensen, M HERRING JENSEN, M Jensen, M. C. Jensen, M. Jensen, M.C. Jensen

628

Publications

33.1K

Citations

H-Index

173

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center Seattle Children's Hospital City Of Hope National Medical Center City of Hope

About

Michael C. Jensen is an author at University of Washington specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	8	8	649
2	Health Sciences	5	5	760
3	Business	4	4	771
4	Education	1	1	16
5	Law	1	1	535

Michael C. Jensen

165

Publications

31.1K

Citations

H-Index

Page 1

	Year	Citations
Current concepts in the diagnosis and management of cytokine release syndrome Daniel W. Lee, Rebecca Gardner, David Porter, Blood	2014	2.7K
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients Cameron J. Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Journal of Clinical Investigation	2016	2.1K
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy Christine E. Brown, Darya Alizadeh, Renate Starr, New England Journal of Medicine Cell TherapyImmunologyImmune RegulationImmunotherapeuticsHigh-grade Gliomas	2016	1.8K
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma Andrew T. Parsa, James S. Waldron, Amith Panner, Nature Medicine Tumor BiologyCell RegulationGliomaMedicineImmunology	2006	1.3K
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults Rebecca Gardner, Olivia Finney, Colleen Annesley, Blood	2017	1.1K
Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates Carolina Berger, Michael C. Jensen, Peter M. Lansdorp, Journal of Clinical Investigation	2008	827
Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy Rebecca Gardner, David Wu, Sindhu Cherian, Blood	2016	737
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma Christine E. Brown, Behnam Badie, Michael E. Barish, Clinical Cancer Research	2015	733
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells Brian G. Till, Michael C. Jensen, Jinjuan Wang, Blood	2008	714
Adoptive Transfer of Chimeric Antigen Receptor Re-directed Cytolytic T Lymphocyte Clones in Patients with Neuroblastoma Julie R. Park, David DiGiusto, Marilyn L. Slovak, Molecular Therapy	2007	593

Page 1